| Literature DB >> 27049128 |
Yasumasa Ikeda1, Mizuki Imao2, Akiho Satoh2, Hiroaki Watanabe3, Hirofumi Hamano4, Yuya Horinouchi4, Yuki Izawa-Ishizawa5, Yoshitaka Kihira5, Licht Miyamoto2, Keisuke Ishizawa6, Koichiro Tsuchiya2, Toshiaki Tamaki5.
Abstract
Skeletal muscle wasting or sarcopenia is a critical health problem. Skeletal muscle atrophy is induced by an excess of iron, which is an essential trace metal for all living organisms. Excessive amounts of iron catalyze the formation of highly toxic hydroxyl radicals via the Fenton reaction. However, the molecular mechanism of iron-induced skeletal muscle atrophy has remained unclear. In this study, 8-weeks-old C57BL6/J mice were divided into 2 groups: vehicle-treated group and the iron-injected group (10 mg iron day(-1)mouse(-1)) during 2 weeks. Mice in the iron-injected group showed an increase in the iron content of the skeletal muscle and serum and ferritin levels in the muscle, along with reduced skeletal muscle mass. The skeletal muscle showed elevated mRNA expression of the muscle atrophy-related E3 ubiquitin ligases, atrogin-1 and muscle ring finger-1(MuRF1), on days 7 and 14 of iron treatment. Moreover, iron-treated mice showed reduced phosphorylation of Akt and forkhead box O3 (FOXO3a) in skeletal muscles. Inhibition of FOXO3a using siRNA in vitro in C2C12 myotube cells inhibited iron-induced upregulation of atrogin-1 and MuRF1 and reversed the reduction in myotube diameters. Iron-load caused oxidative stress, and an oxidative stress inhibitor abrogated iron-induced muscle atrophy by reactivating the Akt-FOXO3a pathway. Iron-induced skeletal muscle atrophy is suggested to involve the E3 ubiquitin ligase mediated by the reduction of Akt-FOXO3a signaling by oxidative stress.Entities:
Keywords: Atrogenes; Iron; Skeletal muscle atrophy
Mesh:
Substances:
Year: 2016 PMID: 27049128 DOI: 10.1016/j.jtemb.2016.01.011
Source DB: PubMed Journal: J Trace Elem Med Biol ISSN: 0946-672X Impact factor: 3.849